日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

High-Throughput 96-Well Nanogroove-Enhanced Electrical Impedance Biosensor for Real-Time Label-Free Cancer Drug Screening.

用于实时无标记癌症药物筛选的高通量 96 孔纳米沟槽增强型电阻抗生物传感器

期刊:Advanced Healthcare Materials
影响因子:9.6
doi:10.1002/adhm.202402057
Choi Jong Seob, Park Hye-Bin, Lee Su Han, Kim Byunggik, Lee Jihoon, Sung Sang-Keun, Su Chia-Yi, Lee JuKyung, Jang Seongjun, Lee Yongjin, Lee Jung Hyun, Kim Hyung Jin, Kim Deok-Ho
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Axillary Lymph Node Dissection Rates and Prognosis From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer

一项比较新辅助化疗与新辅助内分泌治疗治疗雌激素受体阳性、HER2阴性、淋巴结阳性绝经前乳腺癌患者的III期新辅助全身治疗试验：腋窝淋巴结清扫率及预后

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2021.741120
Gwark, Sungchan; Noh, Woo Chul; Ahn, Sei Hyun; Lee, Eun Sook; Jung, Yongsik; Kim, Lee Su; Han, Wonshik; Nam, Seok Jin; Gong, Gyungyub; Kim, Seon-Ok; Kim, Hee Jeong
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2021
文献求助 收藏

Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer

一项比较新辅助化疗与新辅助内分泌治疗治疗雌激素受体阳性、HER2阴性、淋巴结阳性绝经前乳腺癌患者的III期新辅助全身治疗试验的患者报告结局

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2021.608207
Gwark, Sungchan; Ahn, Sei Hyun; Noh, Woo Chul; Lee, Eun Sook; Jung, Yongsik; Kim, Lee Su; Han, Wonshik; Nam, Seok Jin; Gong, Gyungyub; Kim, Seon-Ok; Kim, Hee Jeong
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2021
文献求助 收藏